• DSHS HIV/STD Program

    Post Office Box 149347, MC 1873
    Austin, Texas 78714

    Phone: 737-255-4300

    Email the HIV/STD Program

    Email HIV, STD, Hepatitis C, and TB data requests to the Program - This email can be used to request data and statistics on HIV, STDs, Hepatitis C, and TB in Texas. It cannot be used to get treatment or infection history for individuals, or to request information on programs and services. Please do not include any personal, identifying health information in your email such as HIV status, Date of Birth, Social Security Number, etc.

    For treatment/testing history, please contact your local health department.

    For information on HIV testing and services available to persons living with HIV, please contact your local HIV services organization.

Texas HIV Medication Program


The Texas HIV Medication Program (THMP) provides medications for the treatment of HIV and its related complications for low-income Texans. To qualify for medications, potential clients who meet eligibility criteria complete an application for assistance. Once approved, a client receives medications at an assigned pharmacy in their community.

To learn more about the THMP and find out if you are eligible, see the Frequently Asked Questions. You can apply for the program by downloading and completing the client application. Be sure and review the specific “application instructions” when completing the application. The application and its instructions are located on the THMP document page. If you have more questions or need assistance completing your application, call the THMP toll free at 1 (800) 255-1090.


The THMP is the official AIDS Drug Assistance Program (ADAP) for the State of Texas. The THMP has been in existence since 1987 and provides medications approved by the Food and Drug Administration (FDA) for the treatment of illnesses caused by the human immunodeficiency virus (HIV) and other opportunistic infections in HIV-infected individuals as prescribed by their doctor. THMP also operates the Texas HIV State Pharmaceutical Assistance Program (SPAP) which helps HIV-positive individuals that do not qualify for the full Low-Income Subsidy (extra help) with their out-of-pocket costs associated with Medicare Part D prescription drug plans, including co-payments, deductibles, coinsurance, and during the coverage gap (the "donut hole").


Texas HIV Medication Program Medication Advisory Committee (THMP-MAC)

AGENDA
April 30, 2021 - 1:30 p.m.

Location: Due to the COVID-19 pandemic, this meeting will be conducted online virtually using Microsoft Teams only. There is not a physical location for this meeting. To join the meeting, go to http://texashhsmeetings.org/HIVMAC_April2021.

Closed captioning for this meeting is available. Viewers are asked to highlight the closed captioning symbol "cc" on the bottom of their viewing screen to enable this function.
Attendees who would like to provide public comment should see the Public Comment section below.

  1. Call to Order and Welcome – Natalie Vanek, M.D., Committee Chair
  2. Logistical Announcement and Roll Call – Sallie Allen, Advisory Committee Coordination Office, HHSC
  3. Review and Approval of January 29, 2021, Meeting Minutes (Vote Required) – Sallie Allen, Advisory Committee Coordination Office, HHSC
  4. Department of State Health Services Updates - Manda Hall, M.D., Associate Commissioner of Community Health Improvement
  5. TB/HIV/STD Section Updates - Felipe Rocha, MSSW, Director TB/HIV/STD Section
  6. THMP Update - Rachel Sanor, THMP Manager
    1. THMP-MAC appointment progress
    2. THMP Enrollment
    3. Data Update on Demographics and Actuarial Projections
    4. Budget Mitigation Details
  7. Presentation: Cabotegravir-Rilpivirine – Aimee Metzner, PharmD, AAHIVP, Viiv Healthcare
  8. Sub-Committee Reports
    1. Formulary Sub-committee – Natalie Vanek, M.D.
    2. Governance/Data – Nancy Miertschin
    3. Eligibility – Frank Rosas
  9. Committee to vote on addition of Cabotegravir-Rilpivirine to THMP formulary (Vote Required)
  10. Committee to vote on removal of certain medications from THMP formulary (Vote Required)
  11. Public Comment – Sallie Allen, Advisory Committee Coordination Office, HHSC
  12. Action items and agenda topics for next scheduled meeting July 30th, 2021 – Natalie Vanek, M.D., Committee Chair
  13. Adjourn – Natalie Vanek, M.D., Committee Chair

Public Comment: The Department of State Health Services (DSHS) welcomes public comments pertaining to topics related to the Texas HIV Medication Program. Members of the public who would like to provide public comment are asked to complete a Public Comment form at http://texashhsmeetings.org/HIVMAC_PCReg_April2021.

If you would like to register to provide oral comments, please mark the correct box on the Public Comment registration form. Instructions for providing oral comment will be emailed to you with the information about joining the meeting. Registration must be completed no later than 5:00 p.m., Wednesday, April 27, 2021. Members of the public may also use the Microsoft Teams Live Event Q&A section during the meeting to submit a request to provide public comment. The request must contain your name and the organization you are representing, or that you are speaking as a private citizen as well as your direct phone number. Do not include confidential information or protected health information in comments.

Public comment is limited to three minutes. Each speaker must state their name and either the organization they are representing or that they are speaking as a private citizen. Public members who are using handouts are asked to provide an electronic copy in accessible PDF format. Handouts are limited to two (2) pages (paper size: 8.5” by 11”, one side only). Handouts must be emailed to DSHS staff immediately after registering and include the name of the person who will be commenting. Do not include confidential information or protected health information in handouts. Staff will not read handouts aloud during the meeting, but handouts will be provided to Committee members and State staff. It is not permissible for public speakers to interject or ask questions to Committee members during the rest of the meeting.

Members of the public who would like to provide written public comment to DSHS may email Mary Richards, at Mary.Richards@dshs.texas.gov no later than 5:00 p.m., Tuesday, April 27, 2021. Please include your name and the organization you are representing, or that you are providing comment as a private citizen. Staff will not read written comments aloud during the meeting, but comments will be forwarded to State staff and committee members for their consideration. Comments should not include confidential information or protected health information.

Contact: Questions regarding agenda items, content, or meeting arrangements should be directed to Mary Richards, Pharmacy Coordinator, Department of State Health Services, at Mary.Richards@dshs.texas.gov or via phone at 1-800-255-1090.

This meeting is open to the public. No reservations are required, and there is no cost to attend this meeting.

People with disabilities who wish to attend the meeting and require assistive technology or services should contact Richards, at Mary.Richards@dshs.texas.gov, or 800-255-1090 at least 72 hours prior to the meeting so that appropriate arrangements can be made.

November 6, 2020 – Formulary Addition

A medication has been added to the THMP Formulary:

  • Rukobia (fostemsavir tromethamine), 600 mg tablets, #60 per bottle

The Medical Certification Form and THMP Formulary have been updated. Both can be found on the THMP documents page.

THMP Flyer
THMP Eligibility Flyer (PDF : 782 kB)

THMP Eligibility Flyer (Spanish)
THMP Eligibility Flyer (Spanish)
(PDF : 786 kB)

Take the THMP Customer Survey

THMP Email Lists

Sign up to one or more email lists below today to receive timely and relevant news from THMP:

THMP News

Less frequent updates with news about significant events for the THMP program.

Subscribe to THMP News

THMP Participating Pharmacies

Updates of interest to THMP participating pharmacies.

Subscribe to THMP Participating Pharmacies

THMP Eligibility

Information for ADAP Enrollment Workers and others who assist clients in THMP application submission and their supervisors.

Subscribe to THMP Eligibility


Program applications, guidelines and formulary listings are available on the THMP document page.


THMP homepage | FAQ | Documents | Policies | Pharmacies
Advisory Committee | Medicare | SPAP | Contact Us



Last updated April 16, 2021